Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction
Acquisition initiates Bruker’s entry into functional single-cell biology research solutions ...
Stay updated with breaking news from Project Accelerate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Acquisition initiates Bruker’s entry into functional single-cell biology research solutions ...
Acquisition initiates Bruker’s entry into functional single-cell biology research solutionsBILLERICA, Mass. & EMERYVILLE, Calif.--(BUSINESS WIRE)--#BRKR--Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today announced that they have signed a definitive agreement for Bruker to acquire PhenomeX for...
Operator: Good morning and welcome to Bruker's Second Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions].
Total revenue increased 2.5% year-over-year to $766.0 million. Net income increased 55.6% year-over-year to $16.8 million; reflects 80-basis point expansion in Net income margin. Adjusted...
Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to Nu Skin Enterprises Second Quarter 2023 Earnings Conference Call.